RT Journal Article
SR Electronic
T1 Severe infection among young infants in Dhaka, Bangladesh: effect of case definition on incidence estimates
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.09.24.24314067
DO 10.1101/2024.09.24.24314067
A1 Fung, Alastair
A1 Heasley, Cole
A1 Pell, Lisa G.
A1 Bassani, Diego G.
A1 Shah, Prakesh S.
A1 Morris, Shaun K.
A1 Hamer, Davidson H.
A1 Islam, Mohammad Shahidul
A1 Mahmud, Abdullah Al
A1 Pullenayegum, Eleanor
A1 Saha, Samir K.
A1 Haque, Rashidul
A1 Hossain, Md. Iqbal
A1 Chen, Chun-Yuan
A1 Emdin, Abby
A1 O’Callaghan, Karen M.
A1 Loutet, Miranda G.
A1 Sultana, Shamima
A1 Billah, S. M. Masum
A1 Gaffar, S. M. Abdul
A1 Karim, Enamul
A1 Sayed, Sharika
A1 Yeasmin, Sultana
A1 Hoque, Md. Mahbubul
A1 Ahmed, Tahmeed
A1 Sarker, Shafiqul A.
A1 Roth, Daniel E.
YR 2024
UL http://medrxiv.org/content/early/2024/09/26/2024.09.24.24314067.abstract
AB Introduction Heterogeneity in definitions of severe infection, sepsis and serious bacterial infection (SBI) in young infants limits the comparability of randomized controlled trials (RCTs) of infection prevention and treatment interventions. To inform the design of severe infection prevention RCTs for young infants in low-resource settings, we estimated the incidence of severe infection in an observational cohort of Bangladeshi infants aged 0-60 days and examined the effect of variations in case definitions on incidence estimates.Methods In 2020-2022, 1939 infants born generally healthy were enrolled at two hospitals in Dhaka, Bangladesh. Severe infection cases were identified through up to 12 scheduled community health worker home visits from 0-60 days of age or through caregiver self-referral. The primary severe infection case definition combined physician documentation of standardized clinical signs and/or diagnosis of sepsis/SBI and either a positive blood culture or parenteral antibiotic treatment for ≥5 days. Incidence rates were estimated for the primary severe infection definition, the World Health Organization (WHO) definition of possible SBI, blood culture- confirmed infection, and five alternative severe infection definitions.Results Severe infection incidence per 1000 infant-days was 1.2 (95% CI 0.97-1.4) using the primary definition, 0.84 (0.69-1.0) using the WHO definition of possible SBI, and 0.026 (0.0085- 0.081) using blood culture-confirmed infection. One-third of cases met the primary criteria for severe infection through physician diagnosis of sepsis/SBI rather than the standardized clinical signs and 85% were identified following caregiver self-referral despite frequent scheduled study visits.Conclusion Severe infection incidence in young infants varied considerably by case definition. Using a clinical sign-based severe infection definition may miss a substantial proportion of cases identified by physician diagnosis of sepsis/SBI. In settings where health facilities are accessible, and caregivers seek care for infant illness, frequently scheduled home assessments by study personnel to identify severe infection in infants may not be necessary.Researchers aiming to design a randomized controlled trial (RCT) for severe infection prevention or treatment in young infants require a clinically precise and feasible case definition of severe infection.There is no consensus definition of severe infection for neonates or young infants. A previous systematic review of neonatal sepsis definitions used in RCTs identified a diverse range, including culture-confirmed sepsis, a combination of clinical signs and culture-confirmation, and a combination of clinical signs and laboratory investigation results.Incidence estimates of various severe infection case definitions that can be operationalized in low- and middle-income countries (LMICs) are needed to determine the feasibility of using these definitions in severe infection prevention and treatment RCTs for young infants in these settings.We provide incidence estimates of severe infection in young infants born generally healthy in Dhaka, Bangladesh, during the first 60 days of age using case definitions based on different combinations of clinical signs, antibiotic treatment and microbiologic criteria.We demonstrate that the incidence estimates of severe infection in young infants vary considerably depending on whether a permissive or stringent case definition is adopted.We also demonstrate that in this study, most severe infection cases were identified following caregiver self-referral rather than during scheduled home assessments by study personnel.Our findings may inform the design of future severe infection prevention RCTs in young infants in LMICs by 1) providing incidence estimates of various candidate case definitions, and 2) supporting the planning of optimal outcome surveillance systems that balance the identification of severe infection cases with operational costs.Competing Interest StatementAF received consulting fees from Brigham and Women's Hospital for separate work on the diagnostic accuracy of clinical sign algorithms to identify sepsis in young infants. None of the other authors had competing interests to declare.Funding StatementThe study was funded by the Bill and Melinda Gates Foundation (BMGF) under grant INV-007389 to The Hospital for Sick Children and grant GR-02268 to The International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b). BMGF had an advisory role in the overall study concept and design; however, the BMGF had no role in data collection, analysis, interpretation of data, writing of the article, and the decision to submit the article for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Hospital for Sick Children Research Ethics Board (REB #1000063899) gave ethical approval for this work. The ethical review committee at the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b; PR-19045) gave ethical approval for this work. The ethical review committee at the Bangladesh Shishu Hospital and Institute (formally known as Dhaka Shishu Hospital), the ethical governing body for the Child Health Research Foundation (CHRF) (BICH-ERC-20/02/2019) gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesDe-identified datasets and code files used in the analyses of this study are publicly available at the Borealis online data repository. https://borealisdata.ca/dataset.xhtml?persistentId=doi:10.5683/SP3/MOSXFC https://borealisdata.ca/dataset.xhtml?persistentId=doi:10.5683/SP3/JEDIJY https://borealisdata.ca/dataset.xhtml?persistentId=doi:10.5683/SP3/WKDQYY